Dr. Logie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10212 Lantern Rd
Fishers, IN 46037Phone+1 317-841-5656Fax+1 317-841-5751
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 1980 - 1982
- University of RochesterResidency, Internal Medicine, 1977 - 1980
- University of Virginia School of MedicineClass of 1977
Certifications & Licensure
- IN State Medical License 1982 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2014
- America's Top Doctors for Cancer Castle Connolly, 2013
- Indianapolis Monthly Castle Connolly, 2010-2011, 2013
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 4 citationsPhase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer.Sreeni Chittoor, William R. Berry, David M. Loesch, Keith W. Logie, John Fleagle
Clinical Genitourinary Cancer. 2006-12-01 - 9 citationsPegylated liposomal doxorubicin as single-agent treatment of low-grade non-Hodgkin's lymphoma: a phase II multicenter study.Nicholas J. Di Bella, Myrna Khan, Shaker R. Dakhil, Keith W. Logie, Thomas A. Marsland
Clinical Lymphoma. 2003-03-01 - 19 citationsPhase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer.Scott Saxman, Patrick J. Loehrer, Keith Logie, Doyle Stephens, Frank Workman
Investigational New Drugs. 1991-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: